Literature DB >> 25143328

The ratios of aldosterone / plasma renin activity (ARR) versus aldosterone / direct renin concentration (ADRR).

Piotr Glinicki1, Wojciech Jeske2, Lucyna Bednarek-Papierska2, Aleksandra Kruszyńska2, Małgorzata Gietka-Czernel2, Elżbieta Rosłonowska2, Jadwiga Słowińska-Srzednicka2, Anna Kasperlik-Załuska2, Wojciech Zgliczyński2.   

Abstract

Primary aldosteronism (PA) is estimated to occur in 5-12% of patients with hypertension. Assessment of aldosterone / plasma renin activity (PRA) ratio (ARR) has been used as a screening test in patients suspected of PA. Direct determination of renin (DRC) and calculation of aldosterone / direct renin concentration ratio (ADRR) could be similarly useful for screening patients suspected of PA. The study included 62 patients with indication for evaluation of the renin-angiotensin-aldosterone system and 35 healthy volunteers. In all participants we measured concentrations of serum aldosterone, plasma direct renin, and PRA after a night's rest and again after walking for two hours. The concentrations of aldosterone, direct renin, and PRA were measured by isotopic methods (radioimmunoassay (RIA) / immunoradiometric assay (IRMA)). Correlations of ARR with ADRR in the supine position were r = 0.9162, r(2) = 0.8165 (p < 0.01); and in the up-right position were r = 0.7765, r(2) = 0.9153 (p < 0.01). The cut-off values of ARR and ADRR ≥ 100 presented highest specificity (99%) for the diagnosis of PA; however, quite acceptable specificity and sensitivity (> 80% and 100%, respectively) appeared for the ratios ≥ 30. We suggest that for practical and economic reasons ARR can be replaced by ADRR.
© The Author(s) 2014.

Entities:  

Keywords:  Aldosterone; DRC; PRA; direct renin concentration; plasma renin activity; primary aldosteronism

Mesh:

Substances:

Year:  2014        PMID: 25143328     DOI: 10.1177/1470320313519487

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  7 in total

1.  Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: A meta-analysis.

Authors:  Xiyue Li; Richa Goswami; Shumin Yang; Qifu Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-08-17       Impact factor: 1.636

2.  Age-Related Cutoffs of Plasma Aldosterone/Renin Concentration for Primary Aldosteronism Screening.

Authors:  Linqiang Ma; Ying Song; Mei Mei; Wenwen He; Jinbo Hu; Qingfeng Cheng; Ziwei Tang; Ting Luo; Yue Wang; Qianna Zhen; Zhihong Wang; Hua Qing; Yihong He; Qifu Li; Shumin Yang
Journal:  Int J Endocrinol       Date:  2018-07-16       Impact factor: 3.257

3.  Feasibility of Screening Primary Aldosteronism by Aldosterone-to-Direct Renin Concentration Ratio Derived from Chemiluminescent Immunoassay Measurement: Diagnostic Accuracy and Cutoff Value.

Authors:  Tianqi Li; Yeshuo Ma; Ying Zhang; Yue Liu; Tingting Fu; Ri Zhang; Kai Kang; Yingchao Yang; Lixin Wang; Yinong Jiang; Yan Lu
Journal:  Int J Hypertens       Date:  2019-07-02       Impact factor: 2.420

4.  Aldosterone/direct renin concentration ratio as a screening test for primary aldosteronism: a systematic review and meta-analysis.

Authors:  Hongjiao Gao; Rong Luo; Jindie Li; Haoming Tian
Journal:  Ann Transl Med       Date:  2022-06

5.  Clinical-Pathological Conference Series from the Medical University of Graz : Case No 160: 33-year-old woman with tetraparesis on Easter Sunday.

Authors:  Elisabeth Fabian; Dietmar Schiller; Andreas Tomaschitz; Cord Langner; Stefan Pilz; Stefan Quasthoff; Reinhard B Raggam; Rainer Schoefl; Guenter J Krejs
Journal:  Wien Klin Wochenschr       Date:  2016-09-28       Impact factor: 1.704

Review 6.  New advances in the diagnosis of primary aldosteronism.

Authors:  Hang Shen; Zhi-Xin Xu; Qi-Fu Li
Journal:  Chronic Dis Transl Med       Date:  2020-02-14

Review 7.  Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature.

Authors:  Gregory P Veldhuizen; Rawan M Alnazer; Abraham A Kroon; Peter W de Leeuw
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-12-27       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.